Suppr超能文献

氯氮平致心肌心包炎后成功再次试验。

A successful re-trial after clozapine myopericarditis.

作者信息

Sarathy K, Alexopoulos C

机构信息

K Sarathy, Port Macquarie Base Hospital, Port Macquarie, NSW, Australia. Email:

出版信息

J R Coll Physicians Edinb. 2017 Jun;47(2):146-147. doi: 10.4997/JRCPE.2017.209.

Abstract

Clozapine-induced myopericarditis is a well-described adverse drug reaction. Clozapine is also the most efficacious agent in refractory schizophrenia. We report a case of a patient who was successfully re-trialled on clozapine two years after developing myopericarditis, after which multiple lines of alternative treatment failed. We propose a protocol for safely attempting a re-trial of clozapine in such cases.

摘要

氯氮平诱发的心肌心包炎是一种已被充分描述的药物不良反应。氯氮平也是治疗难治性精神分裂症最有效的药物。我们报告了一例患者,该患者在发生心肌心包炎两年后成功重新试用氯氮平,此前多种替代治疗均失败。我们提出了一个在此类病例中安全尝试重新试用氯氮平的方案。

相似文献

1
A successful re-trial after clozapine myopericarditis.氯氮平致心肌心包炎后成功再次试验。
J R Coll Physicians Edinb. 2017 Jun;47(2):146-147. doi: 10.4997/JRCPE.2017.209.
9
Myocarditis under therapy with clozapine.使用氯氮平治疗期间的心肌炎。
Schizophr Res. 1995 Nov;17(3):293-4. doi: 10.1016/0920-9964(95)00047-x.
10
Myocarditis associated with clozapine treatment.与氯氮平治疗相关的心肌炎。
Aust N Z J Psychiatry. 2000 Oct;34(5):880. doi: 10.1080/j.1440-1614.2000.0822n.x.

引用本文的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验